On International Clinical Trials Day, we're highlighting the importance of clinical trials, without which we would have no new medicines or vaccines.
Dr Janet Valentine explains in the video below. #ICTD@NIHRresearch@HRA_Latest@MHRAgovuk
https://t.co/sE7GErz2lO
Weโre delighted to welcome a new @Plaid_Cymru government under @RhunapIorwerthโs leadership.
We will continue our work to support equitable access to innovation, drive health and economic ambitions and deliver better health outcomes for people in Wales.
Our manifesto sets out how we can work together to achieve these goals: https://t.co/94tawxyMKs
New blog ๐ | @ABPI_UK's Sophie Caseby examines the latest @EFPIA_HQ W.A.I.T. report โ and what it means for NHS patients.
England ranks 7th in Europe for access to new medicines. But for cancer treatments? 14th.
The data matters. The patients behind it matter more.
Read more ๐ https://t.co/cfMt0ljAAU
Medicines supply issues are relatively rare, but when they happen, they can have a serious impact on patients.
Our new report sets out how to improve the supply chain to anticipate risks and respond quickly when disruption occurs.
Read more: https://t.co/wudRpR46wg
Decentralised or hybrid clinical trials can bring research closer to home - boosting access & inclusion.
A new @acmedsci report, supported by us + @NIHRrdn shows how to encourage more of these trials: choice, trust & clearer guidance.
Read more: https://t.co/kcvhMRUXa5
โ The Health Minister has launched the "This is our Health" programme.
๐ค The large scale innovation is designed to establish a clear, shared deal between the NI public and the health and social care system.
๐ More info: https://t.co/p87MpGGliY
We are celebrating World Immunization Week๐
Vaccines have safely protected people, families, and communities for generations and as part of our free learning resources for schools you can find out more about the importance of vaccinations with Ellie.
https://t.co/Ge5dsJ7CcD
New reforms on clinical trials come into force today! The changes include a new faster route for approval of lower-risk clinical trials.
Visit @MHRAgovuk's new clinical trials hub below for more information โฌ๏ธ
New regulations came into effect today (28 April 2026). https://t.co/LaVE333oZ0
The MHRAโs Clinical Trials (CT) Hub provides guidance to help sponsors apply the new regulations.
Visit our Clinical Trials Hub: https://t.co/lpHrLyhskS
The panel discussed how co-creation between industry, academia, government and the NHS is essential to remove barriers and expand access to research. #ABPIconf26
Next up is our clinical trials panel!
Improvements in regulatory performance, alongside the UKโs unique health data assets, are strengthening the environment for commercial and non commercial clinical trials.
For industry, the priorities are clear: predictability, accuracy and speed.
#ABPIconf26
The ABPI Exam offers qualifications to help make sure all industry personnel have the understanding they need to promote medicines ethically. Each year, the ABPI recognises the outstanding exam candidate who has achieved the highest grade.
This year's winner is Pedro Figueiredo Aparicio from Johnson & Johnson Innovative Medicine UK
Many congratulations to Pedro! ๐๐๐
Panellists pointed to the value of bringing together industry, government, academia and the health system to unlock the UKโs full potential.
#ABPIconf26
A strong start to todayโs growth panel on where the UK can win globally.
The discussion pointed to a clear opportunity for the UK at the intersection of life sciences and AI, with healthcare seen as one of the most promising settings for innovation to flourish.
#ABPIconf26
How do we turn the 10 Year Plan into reality? #ABPIConf26
Prevention, earlier intervention, equity in access to treatments, focussing on the patient, 3-year NHS budgets, embracing innovation, empowering clinicians and health and care leaders, better data, partnerships with industry, all these will help, say @swoolnough of @TheKingsFund, Fiona Bride, @NHSEngland, Helen Knight of @NICEComms & @jacoblant of @NVTweeting.
.@swoolnough of @TheKingsFund highlights the green shoots of recovery for the NHS - weโve seen an increase in satisfaction, but from a low base.
Access to treatment matters, and sometimes simple improvements in admin can help. #ABPIConf26
Our President Russell Abberley has highlighted how much life sciences matters to people - to patients, jobs, and the next generation.
We look forward to delivering for them. #ABPIConf26
Great to hear from @zubirahmed at #ABPIConf26
Changes government has made have meant new cancer medicines for patients, and investment in the UK by companies.
Happy to work in partnership to transform patient care and make the UK a leading life sciences economy. @DHSCgovuk
Opening, @TorbettR said the UK is starting to choose growth, innovation
and faster patient access to medicines. We've long known of problems in the UK - 102 medicines launched in the US have not launched in European markets, vs 15 the other way round.